Dr. Tiago Reis Marques - 23 Nov 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Tiago Reis Marques
Issuer symbol
KTTA
Transactions as of
23 Nov 2022
Net transactions value
+$9,320
Form type
4
Filing time
28 Nov 2022, 15:00:14 UTC
Previous filing
21 Oct 2022
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Award $5,000 +5,000 +0.62% $1.00 815,000 23 Nov 2022 Direct
transaction KTTA Common Stock Award $1,030 +1,000 +0.12% $1.03 816,000 23 Nov 2022 Direct
transaction KTTA Common Stock Award $1,230 +1,206 +0.15% $1.02 817,206 23 Nov 2022 Direct
transaction KTTA Common Stock Award $2,060 +2,000 +0.24% $1.03 819,206 25 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.